fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Could penicillin allergy de-labelling lead to better outcomes?

Written by | 15 Nov 2023

Implementation of penicillin allergy de-labelling calls for an understanding of the key barriers and enablers in healthcare systems – topics that the iNAAN and ALABAMA studies address, explains… read more.

What the PALACE study tells us about penicillin allergy de-labelling

Written by | 14 Nov 2023

The PALACE study showed that in people at low-risk of penicillin allergy, a direct oral challenge with penicillin was no less effective than standard allergy testing for determining… read more.

Why penicillin allergy labels might be a bad thing

Written by | 13 Nov 2023

Neil Powell combines the roles of a consultant antimicrobial pharmacist and a clinical researcher at the Royal Cornwall Hospital in Truro.  His current research is focused on the… read more.

Healthy guts containing diverse and mature bacteria are linked to less allergy-related wheezing and asthma in early childhood

Written by | 14 Sep 2023

Babies and young children with more mature communities of bacteria present in their gut are less likely to develop allergy-related wheezing or asthma, according to research presented at… read more.

Skin patch shows promise for toddlers with peanut allergy

Written by | 27 May 2023

A global phase 3 clinical trial that included Ann & Robert H. Lurie Children’s Hospital of Chicago found that a year-long immunotherapy through a skin patch safely desensitized… read more.

How vitamin D3 helps allergic asthma

Written by | 1 May 2023

A vitamin D3 deficiency can lead to severe symptoms, for example in people suffering from allergic asthma. This has already been shown in several studies. However, we still… read more.

Allergic (atopic) asthma/eczema linked to heightened risk of osteoarthritis

Written by | 30 Mar 2023

People with atopic (allergic) diseases like asthma or eczema may be at heightened risk of the painful and often disabling joint condition, osteoarthritis, finds research published online in… read more.

Boiled peanuts could help overcome childhood allergy

Written by | 5 Feb 2023

Boiling peanuts for up to 12 hours could help overcome children’s allergic reactions, according to the results of a clinical trial which found up to 80% of children… read more.

Peanut allergy treatment safest when started for infants under 12 months, researchers find

Written by | 22 Jun 2022

UBC researchers demonstrated in 2019 that pre-schoolers can safely overcome peanut allergies with a treatment called oral immunotherapy. Now they have evidence that the earlier pre-schoolers start this… read more.

National Institute of Health and Care Excellence (NICE) (UK) recommends Palforzia for treating peanut allergy in children – Aimmune/Nestle

Written by | 7 Feb 2022

NICE (UK)-Palforzia from Aimmune/Nestle is recommended, within its marketing authorisation, as an option for treating peanut allergy in children aged 4 to 17. It can be continued in… read more.

Questionable penicillin allergy diagnosis increases risk of MRSA and C. difficile 

Written by | 3 Aug 2018

A retrospective study of outpatient records for millions of  patients in the UK  reveals that  the overuse of broad-spectrum alternative antibiotics among patients who are probably not allergic… read more.

Acetaminophen does not worsen asthma in young children

Written by | 24 Aug 2016

by Bruce Sylvester: Treatment of pain and fever with acetaminophen (Tylenol, etc.) does not exacerbate asthma in young children, researchers reported on August 18 NEJM/New England Journal of Medicine.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.